Pathfinder Cell Therapy Stock Today
| PFND Stock | USD 0.0001 0.00 0.00% |
Performance0 of 100
| Odds Of DistressLess than 44
|
Pathfinder Cell is trading at 1.0E-4 as of the 28th of November 2024, a No Change since the beginning of the trading day. The stock's lowest day price was 1.0E-4. Pathfinder Cell has about a 44 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Pathfinder Cell Therapy are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2024 and ending today, the 28th of November 2024. Click here to learn more.
Pathfinder Cell Therapy, Inc., a development stage regenerative medicine company, focuses on developing novel cell-derived and related therapies for the treatment of various diseases and medical conditions characterized by organ-specific cell damage. The company was founded in 2008 and is headquartered in Cambridge, Massachusetts. The company has 667.16 M outstanding shares. More on Pathfinder Cell Therapy
Valuation
Check how we calculate scores
Pathfinder Pink Sheet Highlights
| CEO | Richard Franklin |
| Business Concentration | Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Pathfinder Cell Therapy [PFND] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 2 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pathfinder Cell's market, we take the total number of its shares issued and multiply it by Pathfinder Cell's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Pathfinder Cell Therapy conducts business under Biotechnology sector and is part of Health Care industry. The entity has 667.16 M outstanding shares.
Pathfinder Cell Therapy currently holds about 4 K in cash with (963 K) of positive cash flow from operations.
Check Pathfinder Cell Probability Of Bankruptcy
Pathfinder Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Pathfinder Cell without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Analysis Now
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
| All Next | Launch Module |
Pathfinder Cell Corporate Executives
Elected by the shareholders, the Pathfinder Cell's board of directors comprises two types of representatives: Pathfinder Cell inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pathfinder. The board's role is to monitor Pathfinder Cell's management team and ensure that shareholders' interests are well served. Pathfinder Cell's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pathfinder Cell's outside directors are responsible for providing unbiased perspectives on the board's policies.
| John Benson | CFO and Treasurer | Profile |
Other Information on Investing in Pathfinder Pink Sheet
Pathfinder Cell financial ratios help investors to determine whether Pathfinder Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pathfinder with respect to the benefits of owning Pathfinder Cell security.